HealthEquity, the nation's largest health savings account (HSA) custodian, saw its shares plummet 6.94% in pre-market trading on Tuesday. The sharp decline was primarily driven by the company's weaker-than-expected revenue guidance for the fiscal year 2026.
For the fiscal year ending January 31, 2026, HealthEquity forecasted revenue between $1.275 billion and $1.295 billion, falling short of the average analyst estimate of $1.32 billion. The company cited an anticipated slowdown in growth for its core HSA business as the primary reason behind the disappointing revenue outlook.
Despite the gloomy fiscal 2026 forecast, HealthEquity reported better-than-expected earnings and revenue for the fiscal third quarter of 2025. The company's non-GAAP earnings of $0.78 per share beat the consensus estimate of $0.72, while revenue increased by 20.6% year-over-year to $300.4 million, slightly exceeding analyst expectations of $305.3 million.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。